Prime Medicine Inc (PRME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -201,142 | -155,063 | -104,481 | -51,890 | -195,882 |
| Depreciation Amortization | 5,384 | 4,296 | 2,989 | 1,536 | 3,034 |
| Accounts payable and accrued liabilities | 996 | 1,577 | -1,461 | 1,884 | -5,257 |
| Other Working Capital | -5,340 | -6,496 | -7,105 | -7,653 | 31,076 |
| Other Operating Activity | 37,538 | 30,378 | 19,789 | 7,266 | 44,164 |
| Operating Cash Flow | $-162,564 | $-125,308 | $-90,269 | $-48,857 | $-122,865 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -104,232 | -132,852 | -40,977 | -45,320 | 74,751 |
| PPE Investments | -4,531 | -4,241 | -3,994 | -2,422 | -7,294 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 1,000 |
| Investing Cash Flow | $-108,763 | $-137,093 | $-44,971 | $-47,742 | $68,457 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 139,512 | 138,950 | 197 | N/A | 189,876 |
| Other Financing Activity | 12,000 | 12,000 | 6,000 | 6,000 | 6,000 |
| Financing Cash Flow | $151,512 | $150,950 | $6,197 | $6,000 | $195,876 |
| Beginning Cash Position | 196,538 | 196,538 | 196,538 | 196,538 | 55,070 |
| End Cash Position | 76,723 | 85,087 | 67,495 | 105,939 | 196,538 |
| Net Cash Flow | $-119,815 | $-111,451 | $-129,043 | $-90,599 | $141,468 |
| Free Cash Flow | |||||
| Operating Cash Flow | -162,564 | -125,308 | -90,269 | -48,857 | -122,865 |
| Capital Expenditure | -4,531 | -4,241 | -3,994 | -2,422 | -7,294 |
| Free Cash Flow | -167,095 | -129,549 | -94,263 | -51,279 | -130,159 |